SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-052447
Filing Date
2024-06-13
Accepted
2024-06-13 16:15:33
Documents
78
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0207671-10q_enzobio.htm   iXBRL 10-Q 806227
2 CERTIFICATION ea0207671ex31-1_enzobio.htm EX-31.1 10119
3 CERTIFICATION ea0207671ex31-2_enzobio.htm EX-31.2 10019
4 CERTIFICATION ea0207671ex32-1_enzobio.htm EX-32.1 3148
5 CERTIFICATION ea0207671ex32-2_enzobio.htm EX-32.2 3175
  Complete submission text file 0001213900-24-052447.txt   5656875

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enz-20240430.xsd EX-101.SCH 62118
7 XBRL CALCULATION FILE enz-20240430_cal.xml EX-101.CAL 55926
8 XBRL DEFINITION FILE enz-20240430_def.xml EX-101.DEF 264984
9 XBRL LABEL FILE enz-20240430_lab.xml EX-101.LAB 523288
10 XBRL PRESENTATION FILE enz-20240430_pre.xml EX-101.PRE 264294
82 EXTRACTED XBRL INSTANCE DOCUMENT ea0207671-10q_enzobio_htm.xml XML 714775
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 241041414
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)